The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases

BACKGROUND: Results of IBCSG‐23‐01‐trial which included breast cancer patients with involved sentinel nodes (SN) by isolated‐tumor‐cells or micro‐metastases supported the non‐inferiority of completion axillary‐lymph‐node‐dissection (cALND) omission. However, current data are considered insufficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Houvenaeghel, Gilles, de Nonneville, Alexandre, Chopin, Nicolas, Classe, Jean‐Marc, Mazouni, Chafika, Chauvet, Marie‐Pierre, Reyal, Fabien, Tunon de Lara, Christine, Jouve, Eva, Rouzier, Roman, Daraï, Emile, Gimbergues, Pierre, Coutant, Charles, Azuar, Anne Sophie, Villet, Richard, Crochet, Patrice, Rua, Sandrine, Bannier, Marie, Cohen, Monique, Boher, Jean‐Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972015/
https://www.ncbi.nlm.nih.gov/pubmed/36127853
http://dx.doi.org/10.1002/cam4.5257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972015/
https://www.ncbi.nlm.nih.gov/pubmed/36127853
http://dx.doi.org/10.1002/cam4.5257

Ejemplares similares